SCHEMBL336895

SCHEMBL336895

CC(C)c1c(C=O)c2ccccc2n1Cc1ccccc1

nearest known ligand 0.68

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.54
ALDH1A1 P00352 5/20 0.53
NPSR1 Q6W5P4 1/20 0.53
MEN1 O00255 5/20 0.52
KMT2A Q03164 5/20 0.52
POLB P06746 2/20 0.52
KDM4E B2RXH2 2/20 0.52
USP2 O75604 1/20 0.52
CYP19A1 P11511 1/20 0.51
PSMD14 O00487 1/20 0.50
P2RX4 Q99571 1/20 0.50
S1PR3 Q99500 1/20 0.47
SMN1; SMN2 Q16637 3/20 0.47
MAPK1 P28482 1/20 0.47
THRB P10828 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
HTT P42858 1/20 0.44
MAPT P10636 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL290260 0.84 S1PR3 (0.53) LMNAALDH1A1NPSR1MEN1KMT2A
SCHEMBL3720179 0.82 S1PR3 (0.54) LMNAALDH1A1NPSR1KMT2AS1PR3
SCHEMBL10624841 0.81 LMNA (0.79) LMNAALDH1A1NPSR1MEN1KMT2A
SCHEMBL4885612 0.81 S1PR3 (0.55) LMNAALDH1A1NPSR1MEN1KMT2A
SCHEMBL1348380 0.80 ALDH1A1 (0.44) LMNAALDH1A1NPSR1MEN1KMT2A
SCHEMBL2345535 0.79 KMT2A (0.60) LMNAALDH1A1NPSR1MEN1KMT2A
SCHEMBL28216521 0.79 CYP19A1 (0.58) LMNAALDH1A1NPSR1MEN1KMT2A
SCHEMBL336487 0.79 S1PR3 (0.50) LMNAALDH1A1NPSR1MEN1KMT2A
SCHEMBL4885352 0.77 S1PR3 (0.67) ALDH1A1POLBS1PR3MAPT
SCHEMBL1348764 0.77 ALDH1A1 (0.41) LMNAALDH1A1NPSR1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8097644-B2 Indole compounds having sphingosine-1-phosphate (S1P) receptor antagonist ALLERGAN, INC. (US) 2012-01-17 US disclosed
US-8097644-B2 Indole compounds having sphingosine-1-phosphate (S1P) receptor antagonist ALLERGAN, INC. (US) 2012-01-17 US disclosed
US-8097644-B2 Indole compounds having sphingosine-1-phosphate (S1P) receptor antagonist ALLERGAN, INC. (US) 2012-01-17 US disclosed
US-20070232682-A1 Indole Compounds having sphingosine-1-phosphate (S1P) receptor antagonist ALLERGAN, INC. (US) 2007-10-04 US disclosed
US-20070232682-A1 Indole Compounds having sphingosine-1-phosphate (S1P) receptor antagonist ALLERGAN, INC. (US) 2007-10-04 US disclosed
US-20070232682-A1 Indole Compounds having sphingosine-1-phosphate (S1P) receptor antagonist ALLERGAN, INC. (US) 2007-10-04 US disclosed
WO-2007112322-A2 INDOLE COMPOUNDS HAVING SPHINGOSINE-1-PHOSPHATE (S1P) RECEPTOR AGONIST AND/OR ANTAGONIST BIOLOGICAL ACTIVITY ALLERGAN, INC. (US) 2007-10-04 WO disclosed
WO-2007112322-A2 INDOLE COMPOUNDS HAVING SPHINGOSINE-1-PHOSPHATE (S1P) RECEPTOR AGONIST AND/OR ANTAGONIST BIOLOGICAL ACTIVITY ALLERGAN, INC. (US) 2007-10-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070232682-A1 Indole Compounds having sphingosine-1-phosphate (S1P) receptor antagonist S1PR1, S1PR2, S1PR3 LMNA 3435/4885ALDH1A1 2262/4885NPSR1 51/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.